Visser, AdeleHoosen, Anwar Ahmed2011-08-032011-08-032011-05Viser, A & Hoosen, A 2011, 'More about... medical virology : Human papillomavirus (HPV)', CME : Continuing Medical Education, vol. 29, no. 5, pp. 214.1016-6742 (print)2078-5143 (online)http://hdl.handle.net/2263/16984The WHO advocates introduction of routine HPV vaccination as part of a national EPI programme provided HPV prevention is considered a health priority, and the programme is logistically feasible and financially sustainable. High vaccine costs are often cited as barriers to national public health usage. However, a recent study in Cape Town showed a cost benefit for routine HPV vaccination use. Cervical cancer screening programmes should continue, as genotypes not included in the vaccines may still cause malignant transformation.enHealth and Medical Publishing GroupHuman papillomavirus vaccineArticle